Spring Issue — April 2006
Ontario Early Researcher Award
Four researchers at the University of Ottawa are among the first laureates of the Ontario Early Researcher Award program, formerly the Premier’s Research Excellence Awards. The Ontario government is investing $30 million over three years in this program.
School of Information Technology and Engineering
Azzedine Boukerche is a Canada Research Chair in Large-Scale Distributed Interactive Simulation Systems and Mobile Computing and Networking. He is developing interactive simulation-based technology for emergency preparedness and distributed collaborative virtual environments. A long-term goal of his research is to develop novel techniques and well founded mechanisms of designing efficient, scalable and meaningful large-scale distributed interactive simulation systems.
Related Links
Department of Biology
Rees Kassen’s work on the experimental study of biodiversity has led to a rethinking of mechanisms responsible for nature’s diversity patterns. His research seeks to answer why there are so many species on the planet by following evolution in real time using microbial populations. He hopes to give a general explanation for diversity patterns across various scales, from genes to ecosystems.
Related Links
Faculty of Common Law
Daniel Gervais is the Oslers Professor of Technology Law at the University of Ottawa, specializing in intellectual property law. Through his research, he looks into the legal and economic criticisms of copyright norms. He is interested in how the Internet affects copyright and how, in turn, copyright affects intellectual property.
Related Links
Faculty of Medicine
Marc Rodger is a haematologist/epidemiologist whose thrombophilia research focuses on discovering novel disease associations and therapeutic interventions for people suffering from thrombophilia, a tendency to develop blood clots. More than one in six people are affected by the disease. There has been a recent explosion in knowledge about thrombophilia, but many questions remain unanswered. His research aims to gain new knowledge of this disease and ultimately prevent illness, disability, and death in people with thrombophilia.